Právní předpis byl sestaven k datu 17.01.2025.
Zobrazené znění právního předpisu je účinné od 17.01.2025.
§1
Předmět úpravy
Toto xxxxxxxx xxxxxxx xxxxxx zařazených xxxxxxxxxxxxxxx xxxxx, který xx xxxxxx x příloze x xxxxxx xxxxxxxx.
§2
Oznámení xxxxxxxxxxx xxxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Evropského xxxxxxxxxx x Xxxx (EU) 2015/1535 ze xxx 9. září 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxx x xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
§3
Účinnost
Toto xxxxxxxx xxxxxx xxxxxxxxx xxxx následujícím xx dni xxxx xxxxxxxxx.
&xxxx;
Xxxxxxxx vlády:
prof. XxXx. Xxxxx, Ph.D., XX.X., x. x.
&xxxx;
Xxxxxxxxxxxxx xxxxx x xxxxxxx zdravotnictví:
prof. XXXx. Válek, XXx., XXX, XXXX, v. x.
Příloha
Seznam xxxxxxxxxx psychoaktivních xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx obecný xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxx |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxx |
XXXX |
6,6,9-xxxxxxxxx-3-xxxxxx-6x,7,8,9,10,10x-xxxxxxxxx xxxxx[x]xxxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxxx |
XXXX; XXX-X6 |
6,6,9-xxxxxxxxx-3-xxxxx-6x,7,8,9,10,10x-xxxxxxxxx xxxxx[x]xxxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(6xX,10xX)-6,6,9-xxxxxxxxx-3-xxxxxx-6x,7,8,9,10,10x-xxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
X xxxxxxxx látky XXX, pokud xx xxxxxxxx x rostlině xxxxxxxxxxx konopí, xxxxxxxxxx xxxxxx, xxxxxx extrakt x tinktura x xxxxxxxxx z xxxxxxxxxxx xxxxxx v xxxxxxxx xxxxxx xxx 0,3 %. Tato xxxxxxx xx nevztahuje xx xxxxxxxxx. |
|
|
Xxxxxxxxxxxxxxxxxxxx |
XXX-X8 |
6,6,9-xxxxxxxxx-3-xxxxx-6x,7,8,9,10,10x-xxxxxxxxx xxxxx[x]xxxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxx |
XXXX; XXX-X4 |
6,6,9-xxxxxxxxx-3-xxxxx-6x,7,8,9,10,10x-xxxxxxxxx xxxxx[x]xxxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxx |
XXXX |
(6xX,10xX)-3-xxxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
X xxxxxxxx xxxxx XXXX, xxxxx xx xxxxxxxx v xxxxxxxx xxxxxxxxxxx xxxxxx, xxxxxxxxxx xxxxxx, konopí extrakt x tinktura a xxxxxxxxx x xxxxxxxxxxx xxxxxx v množství xxxxxx xxx 0,3 %. Xxxx xxxxxxx xx nevztahuje xx xxxxxxxxx. |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
XXXX; XXX-X6 |
(6xX,10xX)-3-xxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
Xxxxxx delta-8 xxxxxxx. |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX-X8 |
(6xX,10xX)-3-xxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
Xxxxxx delta-8 xxxxxxx. |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX; XXX-X4 |
(6xX,10xX)-3-xxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
Xxxxxx xxxxx-8 izomeru. |
|
|
5-Xxxxxxxxxxxxxxxxxx |
1-(5-xxxxxxxxxxxxx-2-xx)xxxxxx-2-xxxx |
|||
|
XXX-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|||
|
X-XXXXX-XXXX |
3-(2X-1,3-xxxxxxxxxxx-5-xx)-2-xxxxxxx-X,2-xxxxxxxx-3-(xxxxxxxxxxx)xxxxxxxxxx |
|||
|
Xxxxxxxx |
X-xxxxxx-1-(5-xxxxxx-2-xxxxxxx)xxxxxx-2-xxxx |
|||
|
2-Xxxxx-xxxxxxxx-X-xxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-(2-xxxxxxxxxx)xxxxxxxxxxxx |
|||
|
3-Xx-XXX |
1-[1-(3-xxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|||
|
3X-XXX |
1-[1-(3-xxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|||
|
3-Xx-XXX |
1-[1-(3-xxxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|||
|
3-Xx-XXXx |
1-[1-(3-xxxxxxxxxxx)xxxxxxxxxx]xxxxxxxxxx |
|||
|
Xxxxxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxx)-xxxxxxxxxxxx |
|||
|
Xxxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxx)xxxxxxxxxx-1-xx |
|||
|
Xxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)-xxxxxxxxxxxx |
|||
|
Xxxxxxxxxxxxxxxxx |
2-(xxxxxxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
|||
|
4'-Xxxxxxxxxxxxxxxxxxxxxxx |
6-(4-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
|||
|
Xxxxxxxxxx |
1,1-xxxxxxxxxxxxx 8-xxxx-11,12,13,13x-xxxxxxxxxx-9-xxx-9X-xxxxxxx[1,5-x]xxxxxxx[2,1-x][1,4]xxxxxxxxxxxxx-1-xxxxxxxxxx |
|||
|
Xxxxxxxxxxxxxxxxx |
7-xxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
|||
|
Xxxxxxxxxxxxxxxxxx |
2-xxxxx-9-xxxxxx-4-xxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|||
|
Xxxxxxxxxxxxx |
2-xxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxxx [4,3-x][1,4]xxxxxxxx |
|||
|
Xxxxxxxxxxx |
2-xxxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxx |
|||
|
6-XX-XXXXX |
2-xxxx-4,5-xxxxxxxxxxxxxxxxxxxxx |
|||
|
X-xxxxxxxxxxxx-3,4-XXX |
1-[2-(3,4-xxxxxxxxxxxxxx)-1-xxxxxxxxxxx]-xxxxxxxxxx |
|||
|
XXXX |
X-xxxxx-1-xxxxxxxxxxx-2-xxxx |
|||
|
2-(4-Xxxxxxxxxxxxxxx-1-xx)-1-xxxxx propan-1-on |
2-(4-methylpiperazin-1-yl)-1-fenylpropan-1-on |
|||
|
2-MEB |
2-(ethylamino)-1-(2-methylfenyl)butan-1-on |
|||
|
2'-Me-PVP |
1-(2-methylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
|||
|
2-Methyl-α-PHiP |
4-methyl-1-(2-methylfenyl)-2-(pyrrolidin-1-yl) xxxxxx-1-xx |
|||
|
3,4-Xx-XxxXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxx-1-xx) xxxxxx-1-xx |
|||
|
3X-XXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxx)xxxxx-1-xx |
|||
|
3X-X-xxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxx)xxxxx-1-xx |
|||
|
3X-α-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|||
|
3-Xxxxxxxxxxxxx |
2-xxxxx-1-(3-xxxxxxxxxx)xxxxxx-1-xx |
|||
|
3'-Xx-XXX |
1-(3-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|||
|
3-Xxxxxx-X-xxxxxx-xxxxxxxx |
2-(xxxxxxxxxxx)-1-(3-xxxxxxxxxxx)-1-xxxxxxxx |
|||
|
4’-Xxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)-1-xxxxxxx |
|||
|
4-Xx-3-XXX |
1-(4-xxxxx-3-xxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|||
|
4X-3-xxxxxx-α-XXX |
1-(4-xxxxx-3-xxxxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxx-1-xx |
|||
|
4X-3-xxxxxx-α-XXX |
1-(4-xxxxx-3-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|||
|
XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|||
|
XXXXxX |
1-(1,3-xxxxxxxxxxx-5-xx)-4-xxxxxx-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|||
|
X,X-xxxxxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxx)xxxxxx-1-xx |
|||
|
X-xxxxxxxxxxxx |
1-(2X-1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx |
|||
|
X-xxxxxxxxxx xxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxxxx)xxxxx-1-xx |
|||
|
X-xxxxxxxxxx xxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxxxx)xxxxxx-1-xx |
|||
|
X-xxxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|||
|
X-xxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx |
|||
|
X-xxx-xxxxx-xxxxxxxxx |
2-[(xxxxx-2-xx)xxxxx]-1-xxxxxxxxxxx-1-xx |
|||
|
α-X2XX |
1,2-xxxxxxx-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|||
|
α-XXXX |
2-xxxxxxxxxx-1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|||
|
3-Xxxxxxxxxxxxxxxx |
2-(3-xxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|||
|
3-Xxxxxxxxxxxxxxxxxx |
2-(3-xxxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|||
|
4Xx-XXX |
5-(4-xxxxxxxxx)-4-xxxxxx-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
|||
|
4Xx-XXX |
5-(4-xxxxxxxxxx)-4-xxxxxx-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
|||
|
4-Xxxxxxxxxxxx |
4-xxxxx-3-(4-xxxxxxxxxx)xxxxxxxx |
|||
|
Xxxxxxxxxxxxxxxxx |
5-xxxxx-3-(4-xxxxx-2-xxxxxxxxxxx)-2-xxxxxx-4(3X)-xxxxxxxxxxxx |
|||
|
Xxxxxxxxx |
2-xxxxx-3-xxxxxxxxxxxxxxx-4(3X)-xx |
|||
|
Xxxxxxxxx |
2-(xxxxxxxxxx)-5-xxxxx-4(5X)-xxxxxxxx |
|||
|
Xxx-(xxxx-xxxxxx-xxxxxxxxxxxx) |
1-(3-xxxxxxxxxxx)-1-(xxxxxxxxxxx)xxxxxx-2-xx |
|||
|
Xxx-3-XXX |
1-(3-xxxxxxxxxx)-1-(xxxxxxxxxxx)xxxxxx-2-xx |
|||
|
Xxx-3-XXX |
1-(xxxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-2-xx |
|||
|
X-xxxxx zolpidem |
N-ethyl-2-[6-methyl-2-(4-methylfenyl)imidazo[1,2-a]pyridin-3-yl]acetamid |
|||
|
Nitrometakvalon |
3-(2-methoxy-4-nitrofenyl)-2-methylchinazolin-4-on |
|||
|
Pagoklon |
2-(7-chlor-1,8-naftyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-1H-isoindol-1-on |
|||
|
Rilmazafon |
5-[[(2-aminoacetyl)amino]methyl]-1-[4-chlor-2-(2-chlorbenzoyl)fenyl]-N,N-dimethyl-1H-1,2,4-triazol-3-karboxamid |
|||
|
3,4-CFP |
1-(3-chlor-4-fluorfenyl)piperazin |
|||
|
4F-MBZP |
1-[(4-fluorfenyl)methyl]-4-methylpiperazin |
|||
|
pBPP |
1-(4-bromfenyl)piperazin |
|||
|
4,4-Dimethyl-1-fenyl-1-pyrrolidin-1-yl-pentan-3-on |
4,4-dimethyl-1-fenyl-1-pyrrolidin-1-yl-pentan-3-on |
|||
|
Methyl 2-xxxxx-2-(xxxxxxxxxx-1-xx) xxxxxx |
xxxxxx 2-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxxx |
|||
|
3,5-XXX-4xx-XXXXXXXX |
X-(1-xxxxxxxxx-2,2-xxxxxxxx-xxxxxx)-5-(4-xxxxxxxxxx)-2-xxxx-4-xxxx-xxxxxxx-3-xxxxxxxxxx |
|||
|
4xx-XXXX-4xx-XXXXXX |
xxxx-4-xx-1-xx 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazol-3-karboxamido)-butanoát |
|||
|
4F-ABINACA |
N-(adamantan-1-yl)-1-(4-fluorbutyl)-1H-indazol-3-karboxamid |
|||
|
5,3-AB-CHMFUPPYCA |
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyklohexylmethyl)-5-(4-fluorfenyl)-1H-pyrazol-3-karboxamid |
|||
|
5,3-ADB-4en-PFUPPYCA |
N-(1-karbamoyl-2,2-dimethyl-propyl)-5-(4-fluorfenyl)-1-pent-4-enyl-pyrazol-3-karboxamid |
|||
|
5B-AKB48 |
N-(1-adamantyl)-1-(5-brompentyl)indazol-3-karboxamid |
|||
|
5F-BZO-POXIZID |
N-[(Z)-[1-(5-fluorpentyl)-2-oxo-indolin-3-yliden]amino] xxxxxxxx |
|||
|
5X-XXXX-XXXX |
xxxxx 2-(1-(5-fluorpentyl)-1H-indol-3-karboxamido)-3,3-dimethylbutanoát |
|||
|
5F-EMB-PICA |
ethyl 2-[[1-(5-xxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxx-xxxxxxxx |
|||
|
XXX-4xx-XXXXXX |
X-(1-xxxxx-1-xxxxxxxx-2-xx)-1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXX-4xx-X-5Xx-XXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-5-xxxx-1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXX-4xx-XXXXXX |
X-(1-xxxxx-1-xxxxxxxx-2-xx)-1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXX-5Xx-XXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-5-xxxx-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXX-X-5Xx-XXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-5-xxxx-1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXX-X-5Xx-XXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-5-xxxx-1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(4-xxxxxxxxxx)xxxxxx-1,4-xxxxxxxxxxxxxxx-3-xxxxxxxxxx |
|||
|
XXX-XXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxx |
|||
|
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXX-XXXX |
2-[2-(1X-xxxxx-3-xx)xxxxxxxxx]-3,3-xxxxxxxxxxxxxxxxx |
|||
|
XXX-X-5Xx-XXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-5-xxxx-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXXX-3XXX-XXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(3-(xxxxxxxxxxxxxx)xxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXXX-XXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
X-XXXXXXX |
X-(1-xxxxxxxxx)-2-[1-[(4-xxxxxxxxxx)xxxxxx]xxxxx-3-xx]xxxxxxxx |
|||
|
X-XXXXXX |
(xxxxxxxxx-1-xx)(3-xxxxxx-2-xxxxxx-2,3-xxxxxxx-1X-xxxxx[x]xxxxxxxx-1-xx)xxxxxxxx |
|||
|
X-XXXXXX |
X-xxxxxxxxx-4-(xxxxxxxxx)xxxxxxxx-1-xxxxxxxxxx |
|||
|
XXXXXX-4XX-XXXXXX |
X-xxxxxx-1-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXX-4xx-XXXXXXX |
X-[(X)-(2-xxx-1-xxxx-4-xxxx-xxxxxxx-3-xxxxxx)xxxxx]xxxxxxxx |
|||
|
XXX-XXXXXXX |
X-[(X)-(2-xxx-1-xxxxxx-xxxxxxx-3-xxxxxx)xxxxx]xxxxxxxx |
|||
|
XXXXX-1Xx-XXXXXXXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxx-X-(1-xxxxxx-1-xxxxx-xxxxx)xxxxxxx-3-xxxxxxxxxx |
|||
|
XXXXX-3XXX-XXXXXXX |
X-(2-xxxxxxxxxxx-2-xx)-1-(3-(xxxxxxxxxxxxxx)xxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
Xxxxx-XX-XxXxXxXxxxx-221 |
(5-(xxxxxxx[2.2.1]xxxx-2-xx)xxxxxx)-2-(2-xxxxxxxxxxx-2-xx)-2,5-xxxxxxx-1X-xxxxxx[4,3-x]xxxxx-1-xx |
|||
|
Xxxxx-XX-XxXxXxxxx |
5-(xxxxxxxxxxxxxxxx)-2-(1-xxxxxx-1-xxxxx-xxxxx)xxxxxx [4,3-x]xxxxx-1-xx |
|||
|
XXXXX-XXXXXX |
1-(xxxxxxxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
|||
|
XXXXX-XXXXXXXX |
1-(xxxxxxxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXXXX-XXXXXXXX |
1-(xxxxxxxxxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXXXX-XXXXX |
X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXXXX-XXXXXX |
1-(xxxxxxx[2.2.1]xxxxxx-2-xxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
|||
|
XXXXX-XXXXXXXX |
(1-(xxxxxxx[2.2.1]xxxxxx-2-xx)xxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXXXX-XxXXXXX |
X-(2-xxxxxxxxxxx-2-xx)-1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXXX-XXXXXX |
xxxxx 3,3-dimethyl-2-[(1-pentylindazol-3- xxxxxxxx)xxxxx] xxxxxxxx |
|||
|
XXXXXX |
1-[(4-xxxxxxxxxx)xxxxxx]-1X-xxxxx-3-xxxxxx |
|||
|
XX-XXXXXXXXXX |
X-{5-xxxx-1-[(4-xxxxxxxxxx)xxxxxx]-4-xxxxxx-2-xxx-1,2-xxxxxxxxxxxxxx-3-xx}xxxxxxxxxxxxxxxxxxxx |
|||
|
XX-XXXXXXX |
X-xxxxxxxxxx-2-(1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xx)xxxxxxxx |
|||
|
XX-XXXX |
X-xxxxxxxxxx-2-(1X-xxxxx-3-xx)xxxxxxxx |
|||
|
XXX-XXX-19 |
X-[(X)-[1-(xxxxxxxxxxxxxxxx)-2-xxx-xxxxxxx-3-xxxxxx]xxxxx]xxxxxxxx |
|||
|
XXX-XXXX-XXXXXXXX |
xxxxxxxxxxxxxxxx 2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamido)-3,3-dimethylbutanoát |
|||
|
CH-PIACA |
N-cyklohexyl-2-(1-pentyl-1H-indol-3-yl)acetamid |
|||
|
MDMB-5Br-INACA |
methyl 2-(5-xxxx-1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
|||
|
XXXX-7Xx-XXXXX |
xxxxxx 2-(7-xxxx-1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
|||
|
XXXX-XXXXXX |
xxxxxx 2-(1-butyl-1H-indazol-3-karboxamido)-3,3-dimethylbutanoát |
|||
|
MDMB-CHMINACA |
methyl 2-[1-(cyklohexylmethyl)-1H-indazol-3-karbox xxxxx]-3,3-xxxxxxxxxxxxxxxx |
|||
|
XXXX-XXXXX |
xxxxxx 2-(1H-indazol-3-karboxamido)-3,3-dimethylbutanoát |
|||
|
NMDMSB |
1-naftyl 4-xxxxxx-3-(xxxxxxxxxxxxxxxxx)-xxxxxxx |
|||
|
XXX-3 |
X-({2-[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-1,3-xxxxxxx-4-xx}xxxxxx)-2-xxxxxxx-X-xxxxxxxxxxxxxxx |
Xxxxxx xxxxxxxxxxxxx psychoaktivních látek, xx xx výslovné xxxxxxx, xxxxxxxxx v xxxxx xxxxxxx ve xxxxx xxxxxxxxx, xxx xxxx stereoizomery xxxxx xxxxxxxxx podle zvláštního xxxxxxxxxx označení a xxxx x esterů xxxxxxxxxxxxxxx xxxxx uvedených x tomto xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxxx xxxxxxxxx.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 11/2025 Sb. xxxxx xxxxxxxxx xxxx 17.1.2025.
Xx xxx xxxxxxxx xxxxxx xxxxxxx xxxxx měněn xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx předpisů x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx jich xxxxxx xxxxxxxxx změna xxxxx uvedeného právního xxxxxxxx.